HUNTINGTON NATIONAL BANK - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$48,511
-1.5%
6,852
-2.0%
0.00%
Q2 2023$49,238
-11.7%
6,994
+4.7%
0.00%
-100.0%
Q1 2023$55,736
-12.4%
6,683
+20.6%
0.00%0.0%
Q4 2022$63,634
-9.1%
5,543
-0.7%
0.00%0.0%
Q3 2022$70,000
+45.8%
5,582
+24.0%
0.00%0.0%
Q2 2022$48,000
-34.2%
4,5010.0%0.00%0.0%
Q1 2022$73,000
+17.7%
4,5010.0%0.00%0.0%
Q4 2021$62,000
-4.6%
4,5010.0%0.00%0.0%
Q3 2021$65,000
-8.5%
4,5010.0%0.00%0.0%
Q2 2021$71,000
+54.3%
4,5010.0%0.00%0.0%
Q1 2021$46,000
+35.3%
4,5010.0%0.00%
Q4 2020$34,000
+126.7%
4,5010.0%0.00%
Q3 2020$15,000
-28.6%
4,5010.0%0.00%
Q2 2020$21,000
+133.3%
4,5010.0%0.00%
Q1 2020$9,000
-43.8%
4,5010.0%0.00%
Q4 2019$16,000
+23.1%
4,5010.0%0.00%
Q3 2019$13,000
-23.5%
4,5010.0%0.00%
Q2 2019$17,000
-54.1%
4,501
+0.0%
0.00%
-100.0%
Q1 2019$37,000
+2.8%
4,500
-0.0%
0.00%0.0%
Q4 2018$36,000
+5.9%
4,5010.0%0.00%0.0%
Q3 2018$34,000
+30.8%
4,501
+0.0%
0.00%
Q2 2018$26,0004,5000.00%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders